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Background: Genetic networks control cellular functions. Aberrations in normal cellular function are caused by
mutations in genes that disrupt the fine tuning of genetic networks and cause disease or disorder. However, the
large number of signalling molecules, genes and proteins that constitute such networks, and the consequent
complexity of interactions, has restrained progress in research elucidating disease mechanisms. Hence, carrying out
a systematic analysis of how diseases alter the character of these networks is important. We illustrate this through
our work on neurodegenerative disease networks. We created a database, NeuroDNet, which brings together
relevant information about signalling molecules, genes and proteins, and their interactions, for constructing
neurodegenerative disease networks.
Description: NeuroDNet is a database with interactive tools that enables the creation of interaction networks for
twelve neurodegenerative diseases under one portal for interrogation and analyses. It is the first of its kind, which
enables the construction and analysis of neurodegenerative diseases through protein interaction networks,
regulatory networks and Boolean networks. The database has a three-tier architecture - foundation, function and
interface. The foundation tier contains the human genome data with 23857 protein-coding genes linked to more
than 300 genes reported in clinical studies of neurodegenerative diseases. The database architecture was designed
to retrieve neurodegenerative disease information seamlessly through the interface tier using specific functional
information. Features of this database enable users to extract, analyze and display information related to a disease
in many different ways.
Conclusions: The application of NeuroDNet was illustrated using three case studies. Through these case studies,
the construction and analyses of a PPI network for angiogenin protein in amyotrophic lateral sclerosis, a
signal-gene-protein interaction network for presenilin protein in Alzheimer's disease and a Boolean network for a
mammalian cell cycle was demonstrated. NeuroDNet is accessible at http://bioschool.iitd.ac.in/NeuroDNet/.
Keywords: Neurodegenerative diseases, Disease gene network, Protein-Protein interaction network, Boolean
network, Systems analysisBackground
Neurodegenerative diseases (NDDs) are characterized by
progressive neurological impairment caused by the accu-
mulation of abnormal proteins and neuronal loss. The
abnormal proteins apparently alter neuronal functions
that lead to the disruption of synapses in neuronal sub-
populations, neural circuitry and higher-order neural* Correspondence: jgomes@bioschool.iitd.ac.in
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reproduction in any medium, provided the orarchitectures within specific regions of the brain. Since
neurological deficits are not necessarily associated with
neuronal loss [1], it is very likely that neurodegenerative
conditions might be caused by neuronal dysfunction.
The challenge lies in understanding how aberrations in
gene regulation, protein-protein interactions, and the
consequent alterations in signaling and metabolic path-
ways results in neuronal dysfunction. The task is even
more daunting considering the vast data that is being
created by genomic and proteomic research in biological
sciences. From the perspective of developing newl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cipher signal-gene-protein interactions that drive neuro-
degeneration? How does one integrate interaction
networks and clinical data to predict cognitive impair-
ment and disease? To answer these questions, it will be
necessary to rummage through information scattered
across public-domain websites and research literature.
Our objective is to gather and consolidate this informa-
tion under one portal for NDDs and provide network
tools to interrogate the data for identifying critical genes,
determine pathways that are aberrant, create protein-
protein interaction (PPI) networks to interpret disease
mechanisms and perform qualitative and quantitative
network analyses.
Previous instances of databases created to address spe-
cific problems underscores the importance of bringing
together information under a common fold for analyses.
The unifying principle for integrating this information
was protein and gene interactions across species as in
the case of BioGRID. BioGRID provides the interactions
for Saccharomyces cerevisiae, Schizosaccharomyces pombe,
Caenorhabditis elegans, Drosophila melanogaster, Mus
musculus and Homo sapiens [2]. Each interaction record in
BioGRID is based on experimental evidence and is linked
to the supporting publication. MINT on the other hand
contains the molecular interactions experimentally verified
and reported in peer-reviewed journals [3]. Similarly, Reac-
tome, a database of human pathways, was created with
entries cross-referenced in a vocabulary associated with
standard databases such as Uniprot, NCBI Entrez Gene,
Ensembl, UCSC, HapMap, KEGG and primary research
literature to PubMed. It describes the role of 5272 human
proteins and 3504 macromolecular complexes in 3847
reactions organized into 1057 pathways [4]. Sage Bionet-
works, ELIXIR, Biomart and InterMine, have recognized
the value of collecting, curating and categorizing data, and
have undertaken the colossal task of creating infrastructure
for the management of open source databases [5-7]. Many
other database resources available online have also been
developed to unify a class of data of interest [8].
Data related to neurodegenerative diseases has also
grown exponentially with recent advances in high through-
put genotyping techniques using microarrays. To enable
interpretation of the insurmountable data, databases have
been created to gather and rationalize the impact of muta-
tions and protein-protein interactions on clinical manifest-
ation of individual diseases. Some of the examples include
the databases for Alzheimer’s disease (AD), amyotrophic
lateral sclerosis (ALS) and Parkinson’s disease (PD). The
AD database AlzGene, was developed to understand the
genetic proclivity of AD and predict candidates for other
complex genetic diseases [9]. AlzGene catalogues all gen-
etic association studies published in the field of AD. Meta-
analyses results of polymorphisms with genotypes arepublicly available at this site. Yang et al. [10] have floated a
database that contains experimentally confirmed substan-
tianigra expressed sequence tags from healthy and PD
patients. The database captures genetic variation, differen-
tial gene expression, gene-regulating elements, mitochon-
drial proteins, and pathways associated with PD-related
genes. To integrate genetic and clinical information on
ALS, Yoshida et al. [11] developed a database that provides
180 unique variants identified in ALS patients along with
the corresponding clinical data. These databases are useful
to both experimentalists and theorists who wish to under-
stand data pertaining to a single disease of their interest in
relation to known information.
Many examples reported in the literature show that re-
construction and analyses of these networks has given a
deeper understanding of disease mechanisms and strat-
egies for therapeutic intervention. Goh et al. [12] has
shown that NDDs possess one of the most connected
networks through a disease-gene network analysis.
Understanding these networks is important because
genes associated with a disease are not randomly posi-
tioned, but occur in clusters that are positively corre-
lated with other similar diseases [13]. The study of
pathway-based genetic analysis in multiple sclerosis
(MS) indicated that the understanding of biological
mechanisms of disease pathogenesis and identification of
drug targets may come from distant associations [14].
Hwang et al. [15] performed dynamic systems analyses
to identify perturbations of cellular processes that were
required for prion replication. PPI analysis of a network
created by combining library and matrix yeast two-
hybrid screens, led to the discovery that GIT1, a GTPase
activating protein that modulates actin polymerization,
spine morphology, and synapse formation in neuronal
cells, enhanced the aggregation of the huntingtin pro-
tein. Further, through these analyses, they detected 6
new huntingtin interacting proteins of unknown function
[16]. Limviphuvadh et al. [17] focused on protein–protein
interaction networks associated with causative proteins of
six neurodegenerative disorders. They investigated correl-
ation among NDDs using domain characteristics and
found that PD and HD showed highest correlation among
them. However, the challenge lies in the development of a
theoretical framework that will enable the organization of
existing data, and permit the interrogation and interpret-
ation of mechanisms causing disease.
It is in this light that we have created a database, Neu-
roDNet, that includes information about twelve neurode-
generative diseases - adrenomyeloneuropathy, Alzheimer
disease, amyotrophic lateral sclerosis, ataxia-telangiectasia,
dentatorubral-pallidoluysian atrophy, Friedreich ataxia,
frontotemporal dementia, Huntington disease, Lewy body
dementia, Parkinson disease, prion disease, progressive
supranuclear palsy. It accounts for the interactions and
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teins. This database is also the first of its kind, which
enables the construction and analysis of NDDs through
PPI, regulatory and Boolean networks. We also present
the results of three case studies, which demonstrate the
power of the analytical tools featured in NeuroDNet.
Construction and content
Database architecture
The NeuroDNet database was developed in MySQL and
is currently hosted on an APACHE http server located in
the computer service centre of the Indian Institute of
Technology Delhi. The database was built in a three-tier
structure - foundation, function and interface (Figure 1).
The foundation tier (ndnGNM) of NeuroDNet contains
all the genes of the human genome-45020 genes of whichFigure 1 NeuroDNet structure and organization. The database has a th
tier consists of human genome data interlinked with the genes causing ND
gene ontology, phenotype and pathway tables associated with NDD-linked
tiers through a user interface.23857 are protein coding. The gene data for ndnGNM
was acquired from the NCBI human genome database
[ftp://ftp.ncbi.nih.gov/gene/DATA/GENE_INFO/Mamma-
lia/]. Placed above ndnGNM is the table ndnDGN that
contains genes associated with neurodegenerative diseases.
Disease description and associated information was col-
lected manually from MeSH [http://www.ncbi.nlm.nih.
gov/mesh/] and OMIM [http://www.ncbi.nlm.nih.gov/
omim/]. The 305 gene populating ndnDGN were the ones
associated with patient data reported in the literature.
These genes include those reported for sporadic and
familial diseases, and in different ethnic groups.
The functional tier consists of six tables - ndnPRO (pro-
teins), ndnINT (human interactome), ndnSNP (SNPs),
ndnONT (gene ontology), ndnPHE (phenotype) and
ndnPAT (pathway). These tables were populated with dataree-tier structure - foundation, function and interface. The foundation
Ds. The functional tier comprises proteins, human interactome, SNPs,
genes. The features offered by NeuroDNet are linked to these two
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archived in different formats in these databases, the data
acquired was recorded in a format that permitted seamless
transition between different databases. The NCBI Gene
ID was retained to enable a cross mapping of the NeuroD-
Net output to other databases. Data for the Protein table
(ndnPRO) was obtained from Uniprot/Swiss-Prot data-
base [http://www.ebi.ac.uk/uniprot/]. The protein-protein
interaction data was assembled in two stages. First, the
interaction data was downloaded from HPRD, BioGRID,
DIP, MINT and Reactome [3,18,19]. Next, a PHP script
was written to traverse across the downloaded files to cap-
ture the gene IDs, protein IDs and protein-protein interac-
tions, and recorded in the ndnINT table. The data
consists of 23857 genes possessing 51388 interaction
edges. The SNP table was constructed using data obtained
from the literature and OMIM database by screening only
those that were associated with the NDDs. The gene
ontology associated with the ndnDGN was acquired
through a MATLAB script from the Gene Ontology Bio-
logical Process category and stored in the ndnONT table.
Similarly, the phenotype associated with the disease genes
was also obtained from published literature and from
OMIM through NCBI; the retrieved data was manually
verified and then stored in the ndnPHE table. Signaling
pathway information obtained from images given in
KEGG, Reactome, BIOCARTA, and Cell SnapShots was
collated, converted into adjacency matrices and then
stored in the ndnPAT table. The collected information
was organized into six signal-protein-gene interaction
sub-tables, namely, Sig-Sig (ndnPSS), Sig-Prot (ndnPSP),
Sig-Gene (ndnPSG), Prot-Prot (ndnPPP), Prot-Gene
(ndnPPG) and Gene-Gene (ndnPGG). The information
contained in these six tables is used to create signal-
protein-gene networks by NeuroDNet when a user
accesses the “Network Model” feature of the interface
programme. The network is constructed in SBML script
assuming first order rates and output as an XML file
which is ready for performing simulations in Celldesigner
if the user can provide the kinetic parameters.
The user interface consists of two modules. The first
module contains the algorithms coded in PHP. It per-
forms computations required to complete the queries
requested by the user. The second module, the graphical
user interface communicates with the first module to
execute a request. It is written in html and it provides
the user with the features offered by NeuroDNet
database.
User interface
The home page of NeuroDNet gives a brief description
of the database with a link for more information. There
are four links given in the welcome panel - Query, Net-
work, Disease Models and Boolean Analysis that enablesa user to explore the different features of the website.
The quick links are meant to take a revisiting user dir-
ectly to a feature of interest. Using the first option
“Query”, the database may be explored under the follow-
ing categories - Disease, Gene, Protein, Polymorphism
and Pathway. The class “Disease” contains the list of
genes grouped by disease. For example, selecting “Alz-
heimer’s disease” gives the list of all the genes recorded
in the database associated with AD. The user is free to
pursue a gene of interest in this list by selecting links
provided in the table displayed. “Gene ID” automatically
connects the user to the corresponding gene page in
NCBI, “Protein” to the corresponding Uniprot page for
this protein, “Reference” to the research article, and
“NDN Gene” to the NeuroDNet database page Gene De-
scription. Gene Description comprises six sections -
Gene, Protein, SNPs, Structures from PDB [http://www.
rcsb.org/], PPI and Network Model. The database may
be explored through links provided in each of these sec-
tions depending on the interest of the user. For example,
selecting protein-protein interaction (PPI) option will
display interacting proteins based on its cellular location.
An option is provided to increase the neighbourhood de-
gree for the protein. This enables the user to expand the
PPI network to include related proteins in the analysis.
At present, the upper limit on the degree is 3. We have
also provided the user with the option of filtering the
PPI network result by grouping it according to function,
phenotype and occurrence in a pathway.
The second option “Network” contains three sub-
categories - PPINet, DiseaseNet, and PathwayNet. The
PPINet window accepts a list of genes or a text file that
are part of a network under study. NeuroDNet processes
this information and outputs a table where the connect-
ivity of the network is shown in terms of the binary asso-
ciations. When the simple example {A2M,APP,APOE} was
submitted in the PPINet window, it gave the binary asso-
ciations between A2M ↔ APOE and APOE ↔ APP. The
output text file can be visualized graphically as a network
using Cytoscape. The Entrez gene ID and Uniprot/Swiss-
Prot protein ID given in the output text file are unique
identifiers that may be used for global representation. The
purpose of the “DiseaseNet” is to determine if interactions
exist between the queried disease and other NDDs
[12,20]. The result is displayed as a text file. “Pathway-
Net” lists pathways contained in ndnPAT that are asso-
ciated with NDDs. The user may select any pathway of
interest and determine the possible associations with
other pathways in the NeuroDNet database. The path-
ways that possess crosstalk with the one of interest are
given in a text file.
“Disease Model” is the third feature offered by Neu-
roDNet. It lists the collection of disease models that are
linked to Celldesigner [http://www.celldesigner.org/]
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database. These models were redrawn in Celldesigner
from their original sources in reported literature. The
user can download the SBML file from the database
and visualize the model using a suitable network
visualization tool. A PubMed reference is included with
each model to refer the user to the original publication
associated with it. These models may be easily
expanded to include additional components for study-
ing the dynamic behaviour of genes or proteins related
to the disease.
The fourth option, “Boolean Analysis”, has been widely
used to model regulatory networks and signaling path-
ways. This feature enables the user to determine the
dynamic behaviour of a network of interest by assuming
that each node of the network possesses a binary state.
The Boolean analysis panel accepts two inputs, Nodes
and Edges, for converting the network into matrices
required for computation. An option is also available for
specifying non-regulated nodes (self-degrading nodes).
The user must provide the network information in the
prescribed format through a window that accepts Boolean
functions and select one of the two Boolean rules hosted
by the database for determining the steady states of the
network. Additional information and illustrative examples
are given in the help link and user manual.
Maintenance and update
All database entries were meticulously curated for accu-
racy. The following procedure was devised for data in-
put, maintenance and update. The data was first
acquired automatically by employing programme scripts.
This primary information was checked against experi-
mental findings described in the original source reported
in the literature. Further, information about the asso-
ciated pathways, phenotypes, proteins and their interac-
tions were crosschecked and then annotated to the
standard syntax. The error-free data was then stored as
primary raw data files from which each of the six tables
were updated automatically. The current data in Neu-
roDNet is up-to-date and will be updated quarterly.
Utility and discussion
The database tools were created to facilitate disease ana-
lyses using a systems-based approach. Using these tools,
the user can identify the critical genes or proteins asso-
ciated with a NDD. The user may study the networks,
for example, using graph-theoretic methods or study the
dynamic behaviour of individual units or the complex
assembly of units that constitute the network. Using
NeuroDNet it is possible to evaluate hypothesis, query
genes implicated or suspected in NDDs, examine experi-
mental data in the light of gene and protein associations
predicted by the network, visualize interactions anddesign experiments to validate predictions, and examine
experimental data using information under one umbrella
offered by this database. We present three case studies
to illustrate the application of NeuroDNet.
Case study 1: Protein neighbourhood network for human
angiogenin protein
ALS is a debilitating neurological disease that affects
humans across ethnic groups. Missense mutations in the
protein angiogenin (ANG) that result in the partial or
complete loss of angiogenic functions have been impli-
cated with ALS [21,22]. Newer therapies for ALS may
arise from a better understanding of mutations in ANG.
Therefore, there is a need to understand how the loss of
angiogenic properties may affect other proteins that are
related directly or indirectly through various interactions
at the cellular level. Through an exhaustive study of
these interactions, it may be possible to elucidate how
these mutations or SNPs lead to apoptosis of motor
neurons.
Through the example of ANG, we illustrate how the
database may be used to generate protein neighbour-
hood networks for visualization and analysis. ALS and
ANG were selected from the Disease and Gene options
from the Query panel respectively to enter the Gene De-
scription page. The graphical view of PPI showed the first
neighbourhood proteins {ACTC1, ACTN2, ATP6AP1,
PTEN, RNH1, TDGF1, TNFSF8} and their locations in a
cellular environment. The interactions may be visualized
using the Cellular View or Graphical View; the result may
also be downloaded and visualized in Cytoscape [http://
www.cytoscape.org/] (Additional file 1: Figure S1).
Increasing the neighbourhood degree increases the
number of interactions and complexity of the interaction
network. ANG is an extracellular protein; when trans-
ported to the nucleus from the cytoplasm, it interacts
with seven proteins (Additional file 1: Figure S1a) that
participate in regulation of angiogenesis (RNH1), cardiac
muscle development (ACTC1, TDGF1, PTEN), vascula-
ture development (ANG, TDGF1, PTEN) and apoptosis
(TDGF1, PTEN, ACTN2, TNFSF8, ATP6AP1). The sec-
ond neighbours arising from these seven proteins in-
clude 119 proteins possessing 124 edges of interactions
(Additional file 1: Figure S1b). Exploring the network
further to include third neighbours recruited an add-
itional 2580 proteins with 4424 edges of interactions
(Additional file 1: Figure S1c). Network expansion to in-
clude higher degree neighbours is useful in identifying
proteins engaging in crosstalk with other signalling path-
ways through direct or indirect interactions. Ahn et al.
[23] had observed that ANG causes up regulation of
Rb1, RBX1, NBN, CDK4, CDC34, SMARCA2, STAT3,
CDK1, and MAp2; whereas down regulation of IκB-
alpha, p55cdc, p35, BRCA, KAP, PCNA proteins in
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When the network was expanded to the third degree
neighbour, we observed that all these proteins are
included in the PPI network result. PPI networks, such
as the one generated for ANG (Figure 2), may be created
for other proteins and correlated with observed experi-
mental observations.Case study 2: PSEN1 network model and effect on
calcium homeostasis
Presenilin-1 and presenilin-2 (PSEN1 and PSEN2), are
transmembrane protein modulators associated with early
onset familial Alzheimer’s disease (FAD) [24]. It is a con-
served polytopic transmembrane protein predominantly
localised in endoplasmic/sarcoplasmic reticulum (ER/SR)
and participates in the cleavage of the amyloid precursor
protein (APP) which results in the formation of amyloid-
β-peptides [25]. The aggregation of the “sticky” form,
amyloid-β42, into fibrillar structures has been established
as one of the mechanisms leading to all known clinical
symptoms of Alzheimer’s disease. Consequently, weFigure 2 PPI network showing how ANG and its neighbours are linke
associated proteins (red nodes) via intermediate proteins identified by expand
NeuroDNet. Proteins that are up-regulated (green circles) or down-regulateddecided to investigate the role of PSEN1 in neuronal cell
death in AD.
NeuroDNet tool under “Gene” was employed to con-
struct the wiring diagram. This interactive tool allows
the user to select a gene of interest from a disease ca-
tegory and retrieve interactions from the information
contained in the six tables of “Pathway” to assemble the
signal-gene-protein interactions. The information is
retrieved and stored as an Excel spreadsheet, which is
then converted into the SBML format using a PHP
script. The XML file is displayed as a network using
Celldesigner (Additional file 1: Figure S2).
PSEN1 is part of the γ-secretase complex involved in
APP cleavage, notch signaling pathway and calcium
homeostasis. The “Network Model” feature of NeuroD-
Net revealed that PSEN1 protein is an important vertex
that regulates the cell proliferation, differentiation and
apoptosis [26-28]. The network gives details of known
interactions of PSEN1 mediated through the vertices
Notch, APP and Ca2+. The information obtained may be
used in verifying experimental results, building global
systems model or examining specific phenomena. Wed to genes causing ALS. ANG (blue node) is connected to ALS
ing the network to include higher neighbourhood levels using
(yellow circles) by ANG in HUVECs appear as the third neighbour of ANG.
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neighbours may be used to understand how calcium leak
from intracellular stores promotes neurodegeneration.
We asked the question whether the loss of channel
function or its permanent opening caused by PSEN1
mutation disrupted calcium homeostasis. To answer this
question we first studied the PSEN1 interactions. The
SBML network generated using NeuroDNet showed
how Ca2+ interacts with channels and regulatory proteins.
The differential equation model described by Marhl et al.
[29] was obtained from the SBML repository [http://www.
ebi.ac.uk/biomodels/]. This model explained complex
intracellular Ca2+ oscillations using Ca2+ kinetics to de-
scribe fluxes from the ER and mitochondria to the cyto-
plasm, and the role of Ca2+ binding proteins in regulating
the homeostasis.
The calcium leak was attributed to the zymogen form
of PSEN1 and the parameter associated with the corre-
sponding equation, the rate constant kleak
PSEN1, wasFigure 3 Effect of leaky channel attributed to PSEN1 on calcium oscil
affects amplitude and frequency of calcium oscillations in cytoplasm, mitoc
mitochondrial Ca2+ concentration (red line) whereas increase in leaky curre
cytoplasm. (b) Phase diagram between cytoplasmic and ER calcium store s
(c) Similarly, breakdown of ER-mitochondria Ca2+ control with increase in le
scale for kleak
PSEN1 is shown on the bottom right.perturbed (from normal to aberrant) over 0.05 - 0.3 s-1
range. We observed that the amplitude of cytoplasmic
Ca2+ oscillations decreased while the frequency
increased (Figure 3a). Absence of the “burst” signal of
Ca2+ in the cytoplasm indicated a severe dysfunction.
When the ER store of Ca2+ was depleted below 0.72 μM,
the cytoplasmic control was lost completely (Figure 3b).
Similar results were observed by Zampese et al. [30] in
PSEN2 mutant SH-SY5Y and HeLa cells. The mitochon-
drial regulation of the ER was also examined through a
phase diagram. The limit cycle observed for normal par-
ameter values disappeared when kleak
PSEN1 increased to
0.3 s-1, suggesting breakdown of ER-mitochondria Ca2+
control (Figure 3c). Our results suggest that PSEN1 mal-
function increased Ca2+ leak frequency, which in turn
was responsible for the loss of ER-mitochondria Ca2+
regulation. Loss of this regulation effectively nullified the
mitochondrial Ca2+ induced Ca2+ release (mCICR). It
was shown that changes in spatiotemporal concentrationlations. (a) Perturbation in rate constant kleak
PSEN1, over 0.05-0.3 s-1 range
hondria and ER. Absence of leaky current shows increase in ER and
nt decreases amplitude and increases frequency (brown line, 0.3 s-1) in
hows loss of regulation of calcium between two organelles.
aky current, is observed in ER-mitochondria phase diagram. The color
Vasaikar et al. BMC Neuroscience 2013, 14:3 Page 8 of 12
http://www.biomedcentral.com/1471-2202/14/3of mCICR caused a permanent opening of the perme-
ability transition pore (PTP) which ultimately triggered
apoptosis [31-33].
An alternative explanation emerges when the ability of
presenilins to form ion channels is considered. The
zymogen form of presenilins localized in the ER/SR
function as calcium channels and is responsible for the
“leak” calcium currents involved in calcium homeostasis
[34,35]. The mechanism of calcium leak into the cytosol
has remained largely unexplained. Hofer et al. [36]
observed a decrease in free calcium in the ER lumen inFigure 4 Mammalian cell cycle network analysis using NeuroDNet. (a)
Transition of states output of the NeuroDNet using a synchronous simulati
cell undergoes is shown (cyclic attractor) (b). The singleton attractor repres
cell to reach G0 phase where intermediate nodes in the path depict the sy
(c) correspond to the state of the nodes (i = 1, 2, . . ., 10) in the order givenstudies where the SERCA (sarco/endoplasmic reticulum
calcium ATP-ases) was inhibited by the addition of
thapsigargin. This leak remained unaffected even when
the RyRs and IP3Rs were inhibited indicating that the
basal leak rate of calcium was dependent on other un-
known mechanisms. However, evidence that is more re-
cent suggests that RyRs and IP3Rs may participate in the
calcium leak under certain pathological conditions and in
apoptotic phenotypes. Structural studies have shown that
the cytoplasmic domain becomes dysfunctional creating a
“channel only” behaviour [37]. Under normal physiologicalCell cycle regulatory graph was redrawn from Fauré et al. [53].
on has been shown. The cell cycle states through which a mammalian
ents a steady state condition of the cell. The trajectory followed by the
nchronous progression (c). The binary sequences shown in (b) and
in Table 1.
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tural ionophores, golgi, endosomes, and the potential dif-
ference between ER and cytoplasm [38]. Although the
literature presents conflicting views on how the basal cal-
cium leak is regulated, it is clear that calcium imbalance in
the cytosol may push the cell into apoptotic state. Aberra-
tion in the PSEN1 network has been implicated in AD
and its role in calcium homeostasis deserves further ex-
perimental investigation.
Case study 3: Mammalian cell cycle - NeuroDNet Boolean
analysis tool
Biological networks comprise the intricate circuitry of
signals, genes, proteins and metabolites that brings
about the kaleidoscope of changes within the cell. The
interactions between the different molecular species,
results in the observed complexity in cellular func-
tions. Usually, computationally manageable sub-
networks are constructed and analyzed to obtain
insight into specific aspects of cellular behaviour. The
dynamics of these sub-networks have been described
with ordinary differential equations (ODE) but the
ODE formalisms is constrained by the size of the sub-
network and the dearth of kinetic and parametric in-
formation [39]. In such circumstances, it is more desir-
able to use Boolean networks, which are based on
logical formalisms.
Boolean networks have been widely used to model gene
regulatory networks and signaling pathways [40-42]. Each
element of the system has a binary state ({0, 1} = {on, off})
and is therefore discrete, deterministic and parameter free
[43]. The Boolean network is a graph, where the node (or
vertex) v denotes in general, a gene or protein, and the
edge e defines the nature of the interaction between two
nodes. A network of N nodes has 2N possible states. Time
evolution of the network may be synchronous or asyn-
chronous and the eventual steady states are calledTable 1 An example of the syntax for describing the logical o
Product Node Syntax
CycD $node[1] $node[1] = $node[1];
Rb $node[2] $node[2] = (!($node[1]) & !($node[4]) & !($node[5]) &
E2F $node[3] $node[3] = (!($node[2]) & !($node[5]) & !($node[10]))
CycE $node[4] $node[4] = ($node[3] & !($node[2]));
CycA $node[5] $node[5] = ($node[3] & !($node[2]) & !($node[7]) & !(
& $node[9]));
p27 $node[6] $node[6] = (!($node[1]) & !($node[4]) & !($node[5]) &
& !($node[1]));
CDC20 $node[7] $node[7] = $node[10];
CDH1 $node[8] $node[8] = (!($node[5]) & !($node[10])) |$node[7] |($n
UbcH10 $node[9] $node[9] = !($node[8]) |($node[8] & $node[9] & ($no
CycB $node[10] $node[10] = (!($node[7]) & !($node[8]));
*!,&, | represents NOT, AND, OR logic gate.“attractor” states. The attractors, represented by the on-off
state of genes in the network, correspond to important
physiological states of the cells. For example, the state
may indicate growth, differentiation or apoptosis [44].
Boolean analyses are particularly useful in cases where a
qualitative insight is sought and for a better understanding
of the network structure without invoking computation-
ally intensive procedures.
More recently, the research has focused on developing
generalized logical formalisms [45], examining robust-
ness of networks [46], using interaction graph represen-
tations [47], investigating scalability across systems [48]
and designing new efficient algorithms [49]. A number
of systems such as, A. thaliana morphogenesis, yeast cell
cycle, T-cell signaling and T-lymphocyte survival signal-
ing, have been studied using Boolean networks to gain
intuitive understanding [50-53].
We illustrate the use of the Boolean analysis tool fea-
tured in NeuroDNet using the mammalian cell cycle
described by Fauré et al. [54] (Figure 4a). Emerging
evidence suggests that a strong relationship exists be-
tween the expression of cell cycle proteins and neurode-
generative diseases [55]. We describe the steps used to
study this mammalian cell cycle to predict cellular fates
(Figure 4a). The Boolean network comprising 10 nodes
and 49 edges explained the emergence of G0 quiescent
phase and non-spurious dynamical cycle. The Fauré
cycle was reconstructed using NeuroDNet’s “Boolean
Network” feature. The network properties {G = (10, 49)}
were first keyed in. Next, the syntax for defining the
logical operations of the network was written in the desig-
nated text window (Table 1). In the equations, the ith node
of a network was represented by $node[i], (i = 1, 2, . . .,
10). The Boolean rules and algorithm for computation
were then selected and executed to obtain the attractor
states (steady states). The sign associated with edge of
the network, qualified the kind of interaction existingperations of the mammalian cell cycle network
!($node[10])) | ($node[6] & !($node[1]) & !($node[10]));
| ($node[6] & !($node[2]) & !($node[10]));
$node[8] & $node[9])) | ($node[5] & !($node[2]) & !($node[7]) & !($node[8]
!($node[10])) |($node[6] & !($node[4] & $node[5]) & !($node[10])
ode[6] & !($node[10]));
de[7] | $node[5] | $node[10]));
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At each node this information was processed using
logic gates such as AND, OR and NOT. The dynamic
status of each node was updated synchronously. The
state of a node {0 or 1} was assigned the result of the
logical operation at each instant, that is












Where Si(t) and Si(t + 1) represent the successive states
of the ith node, Sj(t), aij = ±1 represents interacting nodes
depending on whether the edge is activating or inhibit-
ing. The network details submitted by the user are pro-
cessed by an algorithm written in PHP script residing in
the user interface module. The algorithm outputs a text
file containing the 2N Boolean outcomes and the list of
singleton attractors and cyclic attractors which signify
the states that the network can acquire. The output text
files can be visualized for determining dynamic trajecto-
ries in a suitable network visualization tool such as
Cytoscape (Figure 4b, c). Each attractor state represented
as the binary sequence shown in (b) and (c), corresponds
to the state of nodes taken in the order given in Table 1.
Cyclin D (CycD) controls the expression of retino-
blastoma (Rb), a key tumor suppressor. During the G1
to S phase transition, E2F transcription factor (E2F) acti-
vates transcription of Cyclin E (CycE) and Cyclin A
(CycA), which in turn controls the anaphase-promoting
complex (APC) in cyclic fashion. We obtained one
singleton attractor state that represented the quiescent
G0 phase {0100010100} where each Boolean state corre-
sponds to node (i = 1, 2, . . ., 10) (Table 1). The other
stable states represent cyclic attractors consisting of seven
successive states describing dynamical cycle consistent
with those reported by Fauré et al. [54]. Mutational stud-
ies were also performed using this cell cycle network. The
Boolean network for Rb mutant was executed and it was
observed that the network lost its singleton attractor. In-
stead, a cyclic attractor was created that depicted lack of
restriction point as shown by Novak and Tyson [56]. The
results of this example showed that Boolean modeling tool
correctly predicted the outcomes of the network and its
dynamic behaviour qualitatively.
Conclusion
NeuroDNet contains comprehensive information about
the twelve neurodegenerative diseases under one portal.
The database has a three-tier structure. Since the foun-
dation tier contains data from the human genome upon
which a table with disease-associated genes is con-
structed, it can be easily expanded by adding new tablescontaining genes of other diseases. NeuroDNet offers
the user a bouquet of tools and features to analyze the
information by creating PPI networks, signal-gene-
protein interaction pathways and Boolean networks. The
ANG case study shows how the PPI network may be
extended to include higher degree neighbours and trace
interaction routes between proteins of interest. The PSEN1
example demonstrated how the in-built programmes of
NeuroDNet extracted the information contained in differ-
ent tables of the database to create an interaction pathway.
This case study also explained how PSEN1 is implicated in
mCICR regulation. Finally, the Boolean analysis of the
mammalian cell cycle was used to portray the power of
qualitative analysis. In the absence of kinetic data, the
Boolean network identified the physiological states of the
cell cycle. The network generated by NeuroDNet predicted
cell-cycle states and the G0 attractor state by a simple syn-
chronous method. The features provided enable the user
to identify unexpected disease linkages of genes and pro-
teins. Higher degree neighbourhood networks created in
NeuroDNet can be visualized to determine critical hubs
and crosstalk associations between interacting partners.
The tools may also be used to design directed experiments
that provide better insight and reveal potential druggable
targets. In future, NeuroDNet will be expanded to include
all known neurodegenerative diseases.
Availability and requirements
The current version of the NeuroDNet is hosted freely
at http://bioschool.iitd.ac.in/NeuroDNet/.Additional file
Additional file 1: Figure S1. ANG neighbourhood network created
using NeuroDNet. The complexity of ANG PPI network increases when
higher degree neighbourhood interactions are considered. The figure
shows ANG (yellow) and its first (a), second (b), and third (c) degree
neighbours in light blue, dark blue and green, respectively. Figure S2.
PSEN1 interaction pathway generated using NeuroDNet in SBML format
and visualized using Celldesigner. PSEN1 is a part of γ-secretase complex
involved in Notch signaling and APP processing. It also acts as Ca2+ leaky
channel in ER (inset). The directed graph shows the interactions between
the nodes [activation →; inhibition ]. The locations of nodes in
cellular compartments are also shown. Here, the primary interaction of
PSEN1 with γ-secretase and Ca2+ was used in NeuroDNet to create this
extensive pathway that accounts for the main elements of Notch
signaling, Calcium homeostasis, CAMKK cascade of events mediated
through nodes like NOTCH1, NICD (notch intracellular domain) and CAM
(calmodulin).
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